# Intradiscal rhGDF-5 Phase I/II Clinical Trial

> **NCT00813813** · PHASE1,PHASE2 · COMPLETED · sponsor: **DePuy Spine** · enrollment: 32 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DRUG:** Intradiscal rhGDF-5

## Key facts

- **NCT ID:** NCT00813813
- **Lead sponsor:** DePuy Spine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813813, "Intradiscal rhGDF-5 Phase I/II Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00813813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*